This trial is terminated!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Breast Cancer, Radiation Dermatitis or Erythema
and you are a woman who is
Phase
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The purpose of this study is to evaluate the effects of topical R1 and R2 for prophylaxis of acute radiation dermatitis in patients with breast cancer receiving radiotherapy.
Tris trial is registered with FDA with number: NCT01597921. The sponsor of the trial is Water-Jel and it is looking for 50 volunteers for the current phase.
Official trial title:
Phase II, Double Blinded, Randomized Study of R1 and R2 (Waterjel) Verses Aloe Vera Jell for the Prevention and Treatment of Radiation Induced Dermatitis in Breast Cancer Patients